We subsequently demonstrated that treating in vitro cocultures with STING agonists promoted ifCAF formation and disrupted formation of myCAFs, suppressing CAF-mediated induction of EMT genes in tumor cells (Fig. 7B). The gene discussed is STING1; the disease is neoplasm.